Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
about
Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3.Patient-reported outcome assessment in vasculitis may provide important data and a unique perspectiveImprovement in health-related quality of life in MPO-ANCA-associated vasculitis patients treated with cyclophosphamide plus prednisolone: an analysis of 18 months of follow-up data from the JMAAV study.Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).Current status of outcome measure development in vasculitis.Assessment of disease activity and progression in Takayasu's arteritis.The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexIllness perceptions and fatigue in systemic vasculitis.Patient-reported outcomes in core domain sets for rheumatic diseases.Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.A framework for creating standardized outcome measures for patient registries.A disease activity score for ENT involvement in granulomatosis with polyangiitis (Wegener's).Long-term damage to the ENT system in Wegener's granulomatosis.
P2860
Q30919439-CB1AFBC4-6C01-495D-B2DD-616374440E40Q33607935-021BD40C-D368-4811-8737-A6342673BB4DQ34151461-6EDD3116-1FF5-48CC-9F6D-F4BC21363A15Q35649141-037999BD-06BB-438A-984D-8372A50A570EQ35865798-96DEF23B-0DDB-44D1-B113-70E4E15707E1Q36820838-578C6C8C-DDEC-43A2-A0E5-F382DF931349Q36820858-824B3322-7C86-4C5B-9165-95F5B1751AFEQ36843077-3919007B-A4B2-4D07-960C-857A8A12343BQ37170449-55997A9A-5DE6-43C4-A7ED-1A1606976D28Q37655765-7C0F3CD3-3B13-4D3D-9B22-D5715DC3A317Q38577796-068BE8D7-8331-4BE2-9C36-7EEB4F1A30C2Q39530208-E2B2F121-71CC-4844-83EF-12D5775A8219Q40060881-D65D00B6-1738-4DB1-B699-235F7230EA76Q43512918-D168A011-FD85-4D57-89D6-445240914341Q44238680-CF3F42CA-EC64-4235-9C76-FB5C1AB4B396Q45878080-27E0FB19-1791-47ED-AAF7-057BE58929B8
P2860
Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@ast
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@en
type
label
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@ast
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@en
prefLabel
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@ast
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@en
P2093
P2860
P50
P356
P1476
Progress towards a core set of ...... ulitis. Report from OMERACT 9.
@en
P2093
Karen Herlyn
Maarten Boers
Michael Walsh
Peter A Merkel
P2860
P304
P356
10.3899/JRHEUM.090373
P407
P577
2009-10-01T00:00:00Z